Evaluation of cytochrome P450-mediated drug–drug interactions based on the strategies recommended by regulatory authorities

Author： Kosugi Yohei Hirabayashi Hideki Igari Tomoko Fujioka Yasushi Hara Yoko Okuda Teruaki Moriwaki Toshiya

Publisher： Informa Healthcare

ISSN： 1366-5928

Source： Xenobiotica, Vol.42, Iss.2, 2012-02, pp. : 127-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanism-based inactivation of human cytochrome P450 enzymes: strategies for diagnosis and drug–drug interaction risk assessment

By Venkatakrishnan K. Obach R. S. Rostami-Hodjegan A.

Xenobiotica, Vol. 37, Iss. 10-11, 2007-11 ,pp. : 1225-1256

Informa Healthcare

Access to resources Recommend Favorite

Drug-drug interactions in the metabolism of imidafenacin: Role of the human cytochrome P450 enzymes and UDP-glucuronic acid transferases, and potential of imidafenacin to inhibit human cytochrome P450 enzymes

By Kanayama N. Kanari C. Masuda Y. Ohmori S. Ooie T.

Xenobiotica, Vol. 37, Iss. 2, 2007-02 ,pp. : 139-154

Informa Healthcare

Access to resources Recommend Favorite

CYP Inhibition-Mediated Drug-Drug Interactions

Current Enzyme Inhibition, Vol. 6, Iss. 3, 2010-10 ,pp. : 130-145

Bentham Science Publishers

Access to resources Recommend Favorite

Drug interactions of diclofenac and its oxidative metabolite with human liver microsomal cytochrome P450 1A2-dependent drug oxidation

By Ohyama Katsuhiro Murayama Norie Shimizu Makiko Yamazaki Hiroshi

Xenobiotica, Vol. 44, Iss. 1, 2014-01 ,pp. : 10-16

Informa Healthcare

Access to resources Recommend Favorite

Bioreactor Systems in Drug Metabolism: Synthesis of Cytochrome P450-Generated Metabolites

By Rushmore T.H. Reider P.J. Slaughter D. Assang C. Shou M.

Metabolic Engineering, Vol. 2, Iss. 2, 2000-04 ,pp. : 115-125

Academic Press

Access to resources Recommend Favorite